Neil here.

The cannabis landscape is changing quickly, and there’s never been a better time to take advantage.

Over the past couple of weeks, news broke that two different cannabis-related initiatives will hit the House of Representatives very soon.

If passed, these initiatives have the potential to transform the entire industry as we know it.

Here’s what’s going on…

The Medical Marijuana Research Act

Last week, the Energy and Commerce Committee announced they will soon vote on the Medical Marijuana Research Act.

This bill would reduce or eliminate many barriers faced by those wanted to conduct legitimate medical cannabis research. These barriers include long research approval wait times, expensive security requirements, and complicated protocol reviews.

The bill would also make obtaining research-grade cannabis easier for approved scientists.

These requirements often deter researchers from performing potentially life-saving studies on the benefits and effects of medical marijuana.

And without obstacles like these in the way, the medical cannabis industry has the potential to grow a whole lot faster.

The MORE Act

This month, the House of Representatives will vote on the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, a bill that would legalize cannabis at a federal level.

If it’s passed, the bill would take cannabis off the list of Schedule I drugs – the drugs considered to be the most dangerous. It would create a process to expunge cannabis-related convictions and arrests, and it would dedicate a federal tax to funding for communities negatively affected by the war on drugs.

This is the first time this type of bill has ever made it to the House floor, and it’s a sure sign that cannabis is gaining legitimacy on an even wider scale.

This is big news for the cannabis industry… but I’m surprised it’s taken this long for initiatives like these to reach the House floor.

Around 66% of Americans support full cannabis legalization, while 80% support medical cannabis legalization. Eleven states have completely legalized cannabis, while 33 states have legalized it medically.

And investor dollars have been pouring into the space for years. From just 2018 to 2019, venture capital investments hit $2.62 billion dollars, and I expect that number to keep growing.

The cannabis industry as a whole made over $5 billion in sales in 2019, with a projected value of $73 billion by 2027.

And if they pass, government initiatives like these will give the cannabis industry the validation it needs to keep booming well into the future.

Because cannabis related companies – especially startups – have the potential to see growth unlike ever before in the coming months and years.

That’s why I want to help you source some of the best cannabis opportunities out there before this industry booms.

And today, I’ve got my eye on a tiny company in the medical cannabis space with plans to grow from $40 million to $21.6 billion dollars over the next few years.

At the helm of this company is a Harvard-trained doctor who risked his entire reputation and career to begin treating his patients with cannabis.

He’s spent 11 years underground perfecting 27 different potential medical cannabis cures that are as close to miracles as medicine will allow. They have the potential to treat everything from seizures and PTSD to dementia and cognitive decline… and that’s only the beginning.

This guy is the real deal, and his startup could soon be the fasting-growing company in the world. And now you have a shot at getting in while they’re still private and at a low valuation.

My friend and colleague Don Yocham is speaking with this doctor and breaking down this one-of-a-kind opportunity now. Just click here to learn all about it.

I’ll be back soon with another update.

Until next time,

Neil Patel